Try our Advanced Search for more refined results

Barba et al v. Shire US, Inc. et al

  1. November 09, 2016

    $15M Deal To End Adderall Buyers' Class Action Wins OK

    A Florida federal judge approved a nearly $15 million settlement Wednesday ending a consumer class action accusing Shire US Inc. of paying rival drugmakers to delay selling cheaper versions of its attention deficit drug Adderall, overruling objections that included allegations class counsel padded their fee request.

  2. October 27, 2016

    Adderall Buyers Deride Objections To $15M Settlement

    Consumers in a class action accusing Shire US Inc. of paying rival drugmakers to delay selling cheaper versions of Adderall have asked a federal judge to overrule objections to a proposed settlement worth nearly $15 million that they say are not well-intentioned.

  3. April 08, 2016

    Adderall Buyers Seek Approval Of $15M Pay-For-Delay Deal

    Consumers accusing Shire US Inc. of paying rival drugmakers to delay selling cheaper versions of Adderall asked a Florida federal judge Thursday to give initial approval to a settlement worth nearly $15 million, calling it a "tremendous deal" for the class.

  4. February 11, 2016

    Shire, Adderall Buyers Agree To Settle Pay-For-Delay Case

    Consumers accusing Shire US Inc. of paying rival drugmakers to delay selling cheaper versions of Adderall have reached a principled agreement with the drug company to settle the case, asking a Florida federal court on Thursday to vacate all scheduled court dates and deadlines.

  5. January 27, 2016

    Shire Expert Opinions Draw Fire In Adderall Antitrust Suit

    Consumers accusing Shire US Inc. of paying off rivals to delay selling cheaper versions of Adderall objected Tuesday to a Florida magistrate judge's recommendation that certain testimony from the drugmaker's expert witness be allowed at trial, saying he misinterpreted the U.S. Supreme Court's Actavis ruling.

  6. January 20, 2016

    Consumers Fight For Class Certification In Adderall Suit

    Consumers accusing Shire US Inc. of paying off rivals to delay selling cheaper versions of Adderall fired back Tuesday at the company's contention that a Florida federal judge was wrong to recommend they get class certification. 

  7. January 06, 2016

    Adderall Antitrust Class Shouldn't Win Cert., Shire Says

    Shire urged a Florida federal court Tuesday to reject a recommendation that a class of consumers be granted certification in an antitrust lawsuit accusing the pharmaceutical giant of paying off generic rivals to delay selling cheaper versions of Adderall, saying the wrong legal standards were used.

  8. November 13, 2015

    Privileged Docs In Adderall Pay-For-Delay Suit Still Off-Limits

    A putative class accusing Shire US Inc. of paying generic rivals to delay selling cheaper versions of Adderall was thwarted Thursday in their attempt to access communications between the pharmaceutical company and its counsel, as a Florida federal judge ruled the crime-fraud exception to attorney-client privilege did not apply.

  9. October 30, 2015

    Adderall Purchasers Push For Cert. In Pay-For-Delay Suit

    A group of consumers on Friday continued fighting for class certification in a suit accusing Shire US Inc. of paying off generic rivals to delay selling cheaper versions of Adderall, saying the claims aren't too late and ascertaining qualified purchasers isn't too difficult.

  10. October 22, 2015

    Adderall Buyers Defend Expert Report Deemed Late By Shire

    A putative consumer class that alleges Shire US Inc. paid off rivals to delay generic versions of Adderall defended on Wednesday an expert report they filed with the Florida federal court last month, saying the drugmaker's objections over its timeliness are meritless.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!